BEUDAMED
    FDA Adverse Event Injury Summary report: N

    GORE® EXCLUDER® AAA ENDOPROSTHESIS

    MDR report key: 17848098 · Received September 29, 2023

    Report

    Report Number
    3013164176-2023-01846
    Event Type
    Injury
    Date Received
    September 29, 2023
    Date of Event
    August 28, 2023
    Report Date
    September 29, 2023
    Manufacturer
    W. L. GORE & ASSOCIATES, INC.
    Product Code
    MIH
    PMA / PMN Number
    P020004
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    JA
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    H.6. INVESTIGATION FINDINGS CODE C19: THE DEVICE REMAINS IMPLANTED AND IS NOT AVAILABLE FOR ANALYSIS. A REVIEW OF THE MANUFACTURING RECORDS FOR THE DEVICE VERIFIED THAT THE LOT MET ALL PRE-RELEASE SPECIFICATIONS. W. L. GORE & ASSOCIATES, INC. (GORE) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY GORE, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. BLANK FIELDS PRESENT ON THIS REPORT INCLUDE REQUIRED FIELDS AND FIELDS DETERMINED TO BE NOT APPLICABLE. BLANK REQUIRED FIELDS INDICATE THAT THE INFORMATION WAS NOT PROVIDED, WAS DEEMED UNAVAILABLE OR WAS NOT APPLICABLE. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, GORE, OR ITS ASSOCIATES THAT THE DEVICE, GORE OR ITS ASSOCIATES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE A LEGAL ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY DEFECTS OR HAS MALFUNCTIONED, AS DEFINED FROM A LEGAL STANDPOINT. THESE WORDS ARE INCLUDED IN THE REPORT AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT.

    Description of Event or Problem · 0

    THE FOLLOWING INFORMATION WAS REPORTED TO GORE: ON (B)(6) 2023, THIS PATIENT UNDERWENT AN ENDOVASCULAR TREATMENT FOR BILATERAL COMMON ILIAC ARTERY ANEURYSMS USING GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS (IBE) AND GORE® EXCLUDER® AAA ENDOPROSTHESIS. THE PATIENT HAD PREVIOUSLY UNDERGONE AN ABDOMINAL AORTIC GRAFT REPLACEMENT USING J GRAFT (JAPAN LIFELINE CO., LTD) ON (B)(6) 2016. DURING THE PROCEDURE, A SET OF IBE DEVICES WAS IMPLANTED ON EACH SIDE OF RIGHT AND LEFT ILIAC ARTERIES. SUBSEQUENTLY, ILIAC BRANCH COMPONENTS ON BOTH SIDES WERE EXTENDED PROXIMALLY BY ADDING TWO CONTRALATERAL LEG ENDOPROSTHESES IN A WAY TO LINE THE PREVIOUSLY IMPLANTED J GRAFT USING A KISSING BALLOON TECHNIQUE. THE PATIENT TOLERATED THE PROCEDURE. ON (B)(6) 2023, THE PATIENT WAS FOUND TO HAVE A WEAK PULSE IN THE RIGHT LEG FOR WHICH AN ANGIOGRAPHY WAS PERFORMED. IT WAS FOUND THAT THE CONTRALATERAL LEG ENDOPROSTHESIS (PLC231000J) PLACED ON THE RIGHT SIDE WITHIN THE J GRAFT HAD BEEN OCCLUDED WITH A THROMBUS. AS A TREATMENT, A FEMORAL-FEMORAL BYPASS WAS PERFORMED. THE PATIENT TOLERATED THE PROCEDURE. ACCORDING TO THE REPORTING PHYSICIAN STATED AS FOLLOWS: THE PLC231000J WAS PLACED ON THE SIDE OF THE INNER CURVATURE OF AORTA. IN ADDITION, THE PROXIMAL END OF THE PLC231000J WAS PLACED JUST BELOW THE ANASTOMOSIS SITE OF THE J GRAFT WHICH HAD BEEN NARROWED DOWN TO 12MM DIAMETER DUE TO STENOSIS. ALTHOUGH A KISSING BALLOON TECHNIQUE WAS UTILIZED, THE LOCATION WHERE THE PLC231000J WAS IMPLANTED MIGHT HAVE MADE IT EASY FOR THE STENT GRAFT TO BECOME OCCLUDED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2271907 GORE® EXCLUDER® AAA ENDOPROSTHESIS SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W. L. GORE & ASSOCIATES, INC.

    Patients

    Seq Age Sex Outcome Treatment
    1 82 YR Male Required Intervention